Subscribe to RSS

DOI: 10.1055/s-0040-1712840
Oxidative Stress is Independent Factor for End-stage Renal Disease in Type 2 Diabetes Mellitus Patients
Authors
Funding This work was supported by intramural funding from Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi.
ABSTRACT
An imbalance between oxidant and antioxidants is thought to precede the development of renal lesions. The aim of present study is to determine the relationship between oxidative markers and severity of microalbuminuria in patients with type 2 diabetes mellitus (T2DM). A total of 100 T2DM patients (50 males and 50 females) participated in this study. They were screened for microalbuminuria along with oxidative status in patients. Microalbuminuria was detected by measuring the albumin to creatinine ratio (ACR) in urine samples. Patients were divided into two groups; normoalbuminuria (n=36) and microalbuminuria (n=64) as per the ACR levels. No difference in the groups was observed in terms of age, sex, glycated hemoglobin (HbA1c) and blood pressure. The level of oxidative stress was significantly higher in microalbuminuria group of T2DM patients. A significant correlation was observed between ACR and lipid peroxidation (MDA) levels. We conclude that oxidative stress is one of the important mediators of end-stage renal disease (ESRD).
Keywords
Type 2 diabetes mellitus - microalbuminuria - diabetic nephropathy - albumin to creatinine ratio - oxidative stressPublication History
Article published online:
09 May 2020
© .
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
-
References
- 1 IDF Diabetes Atlas (2017), 8th edn. International Diabetes Fedration, 1-150.
- 2 Van Buren PN, Toto R (2011). Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis 18(1): 28-41.
- 3 Bakker AJ (1999). Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 22: 307-313.
- 4 American Diabetes Association (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1): S62-S69.
- 5 Chandra K, Khan W, Jetley S, Ahmad S, Jain S (2018). Antidiabetic, toxicological, and metabolomic profiling of aqueous extract of Cichorium intybus seeds. Pharmacogn Mag 14: 377.
- 6 Palatini P (2003). Microalbuminuria in hypertension. Curr Hypertens Rep 5: 208-214.
- 7 Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S (2007). Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56:1010-1013.
- 8 Ogawa S, Nako K, Okamura M, Senda M, Mori T, Ito S (2011). Aliskiren reduces albuminuria and oxidative stress, and elevates glomerular filtration rates in Japanese patients with advanced diabetic nephropathy. Hypertens Res 34: 400-401.
- 9 Toblli JE, Cao G, Giani JF, Muñoz MC, Angerosa M, Dominici FP (2011). Long-term treatment with nebivolol attenuates renal damage in Zucker diabetic fatty rats. J Hypertens 29: 1613-1623.
- 10 Wu LL, Chiou CC, Chang PY, Wu JT (2004). Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 339: 1-9.
- 11 Fukami K, Ueda S, Yamagishi S, et al (2004). AGEs activate mesangial TGF-β–Smad signaling via an angiotensin II type I receptor interaction. Kidney Int 66: 2137-2147.
- 12 Naidoo DP (2002). The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes. Cardiovasc J S Afr 13: 194-199.
- 13 Satchell SC, Tooke JE (2008). What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia 51: 714-725.
- 14 Giugliano D, Ceriello A, Paolisso G (1996). Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267.
